After 24-week treatment , the clinical effect and safety were evaluated using the International Prostatic Symptom Score ( I-PSS ) , quality of life ( QOL ) , maximum flow rate ( Qmax ) , average flow rate ( Qave ) , residual urine volume ( RUV ) , total prostatic volume ( TPV ) , etc. .